Genadur

Quick links to important sections

Genadur

Method of action: Nutritive Agent

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Genadur

Property Description
Active ingredient Biotin (Vitamin B7 / H)
Form Hydrosoluble Nail Lacquer, Oral Tablet
Pharmacological class Water-Soluble Vitamin, Nutritive Agent
General purpose Support for fragile/brittle nails and nail dystrophy
Origin Essential Nutrient (Biotin), Synthetic/Derived Excipients

Genadur is a prescription-only dual-component therapeutic system, uniquely designed for the systemic and topical support of the nail unit in patients experiencing nail dystrophy and fragility. It is classified as a combination product, which integrates a specialized hydrosoluble nail lacquer with an accompanying oral Biotin supplement tablet. This specific pairing of administration routes represents a distinctive feature, aiming for comprehensive structural support that addresses both the internal and external factors contributing to nail weakness.

Composition and Classification

Genadur’s functionality is rooted in its two-component delivery. The foundational ingredient is Biotin, an essential nutrient and water-soluble B-vitamin (Vitamin H or B7), which functions as a crucial cofactor in metabolic processes, a role widely recognized and supported by pharmacological studies. The lacquer, classified as a Topical Nail Product, is differentiated by its hydrosoluble nature, unlike traditional solvent-based polishes. This formulation is enriched with secondary strengthening agents, including Hydroxypropyl Chitosan and Methyl Sulfonyl Methane (MSM), carried in an ethanol and water-based vehicle.

General Purpose and Mechanism

The overall purpose of Genadur is the relief of symptoms and signs associated with fragile, brittle, or splitting nails. The product is indicated to protect damaged nails from the effects of moisture and physical stress, thereby improving the nail's mechanical resilience. This functionality is achieved through the dual mechanism of supplying the Nutritive Agent Biotin internally while the externally applied lacquer actively binds to the nail keratin. This combination is specifically intended to structurally support the nail unit, working to assist the body's natural processes in generating and maintaining more robust, structurally sound nail tissue.

What side effects are possible with Genadur?

Possible Side Effects and Safety Information

The safety profile of Genadur, which includes a systemic Biotin supplement and a topical nail lacquer, is derived from official regulatory documentation and reflects the known characteristics of its components. Due to Biotin being a water-soluble vitamin, systemic adverse effects are typically documented with low frequency.


Official Adverse Reactions by Classification

The majority of adverse reactions officially documented in regulatory sources fall into lower frequency categories, as defined by the International Council for Harmonisation (ICH) guidelines (e.g., Rare or Frequency Not Known).

System-Organ Class Frequency Reported Reaction(s)
Immune System Disorders Rare Hypersensitivity reactions (allergic reactions)
Skin and Subcutaneous Tissue Disorders Rare Urticaria (hives), generalized skin rash
Gastrointestinal Disorders Frequency Not Known Mild, non-specific nausea
Administration Site Conditions Frequency Not Known Localized irritation or redness from the topical lacquer

The most clinically significant adverse reaction documented in official labeling is the potential for a severe form of hypersensitivity, or anaphylaxis, which is classified as a rare event.


Critical Safety Constraint: Laboratory Test Interference

A central regulatory safety note for systemic Biotin is the requirement to be aware of its potential to interfere with certain laboratory immunoassay tests. This constraint is critical because Biotin intake can lead to inaccurate test results, potentially affecting the diagnosis or monitoring of other medical conditions. This issue applies to all patient populations taking Biotin and is officially noted by government health authorities. Use of the product is formally contraindicated in individuals with a known history of hypersensitivity to any component of the oral tablet or topical lacquer.

Overdose and Emergency Response

Overdose Map: Overdose and when to seek help — official regulatory information for Genadur

Overdose Scope

Domain Official Regulatory Statement
Documented overdose presentations No specific toxic clinical symptoms are reliably documented, as Biotin is a water-soluble vitamin. The primary presentation is the occurrence of clinically significant incorrect results in certain laboratory tests.
Physiological systems affected (as stated in label) Diagnostic interference affecting the cardiovascular system (via troponin assays) and the endocrine system (via hormone assays, such as TSH).
Dose-related or exposure-related factors (if applicable) Overdose risk is associated with high levels of Biotin in the blood, often resulting from high-dose supplements, which causes concentration-dependent assay interference.
Population-specific overdose notes (if applicable) No specific regulatory notes are provided regarding differential toxicity or severity based on age or organ impairment.
Emergency-response statements (as written in official documents) Patients should seek immediate medical attention or contact Poison Control if a large amount is ingested or if a severe reaction is suspected.
When immediate medical help is required (label-derived phrasing only) Immediate medical care must be sought, and the medical team must be informed of Biotin use to ensure accurate interpretation of critical test results.

Overdose Classifications (high-level)

Classification Aspect Official Regulatory Statement
Severity classification (as defined in official documents) The U.S. Food and Drug Administration (FDA) classifies the resulting diagnostic risk as a significant safety issue that may lead to serious health consequences, including missed heart attack diagnosis.
Regulatory basis (EMA / FDA / etc.) U.S. Food and Drug Administration (FDA) Safety Communications and National Institutes of Health (NIH) fact sheets.
Overdose-context constraints (as defined in official documents) No specific antidote is known; management is limited to symptomatic and supportive treatment.

Resulting Overdose Structure

Official overdose statements: • Overdose may lead to falsely low results for cardiac troponin, a critical biomarker for heart attack diagnosis. • Biotin interference has been associated with adverse events, including death, linked to resulting misdiagnosis. • High levels of Biotin may also cause falsely high or low results in thyroid hormone assays. • Patients must disclose all Biotin intake to healthcare providers and laboratory personnel to mitigate the risk of incorrect test results.

Connection to the overall overdose profile (2–4 sentences): The regulatory overdose profile for this product is defined by the risk of diagnostic error rather than direct toxicity. The danger stems from interference with critical laboratory tests, particularly troponin, which carries the severe outcome risk of a missed heart attack diagnosis according to FDA warnings. This official classification mandates immediate help-seeking and full disclosure of Biotin use to medical staff.

Therapeutic Uses of Genadur

What Genadur Treats: Main Uses and Benefits

Genadur is commonly used to help manage symptoms related to nail dystrophy and associated structural deficiencies. Clinical evidence suggests that biotin supplementation may assist with improving symptoms related to brittle nails, including enhancement of nail firmness, hardness, and thickness, which may help improve day-to-day comfort during symptomatic periods. The therapeutic utility plays a role in managing symptoms of structural weakness, including chronic brittle nails, persistent nail splitting (onychoschizia), and surface irregularities like longitudinal ridging or trachyonychia.


Therapeutic Domains and Patient Benefit

This treatment is primarily applied across domains where additional symptomatic support is needed for managing symptoms of structural weakness. The support helps ease the overall symptom burden associated with chronic weakness and may assist with managing symptoms that interfere with the aesthetic appearance of the nail plate. The product may be part of symptomatic management in conditions characterized by periods of heightened symptoms, providing additional support in specific dermatological presentations, such as mild to moderate nail psoriasis. Furthermore, the specialized lacquer supports the patient by providing external protection from chronic environmental damage stemming from moisture and harsh chemicals.

“This supportive treatment assists with maintaining functional stability and offers symptomatic relief that helps patients cope more steadily with symptom fluctuations.”

Quick Fact: Support for Symptoms of Structural Nail Damage Genadur is commonly used to help manage symptoms of structural instability, and may assist with improving nail resistance and durability when dealing with occupational or environmental stressors.

Eligibility and Restrictions for Use

Eligibility and Contraindications for Genadur

Genadur (hydrosoluble nail lacquer) is a prescription topical product for use on the nails. The official regulatory documents define strict criteria for who can and cannot use this medicine.

Classification Eligibility Status/Restriction
Populations Contraindicated Individuals with known hypersensitivity (allergy) to any component of the Genadur formulation.
Route/Site Restrictions Must be used for external use only on the nails.
Condition Restrictions Must not be applied to open wounds.
Prohibited Use Must not be ingested and is not for ophthalmic use (use in the eyes).

Use of Genadur is specifically limited to the application on intact or damaged nails. There are no explicit age-related restrictions or specific eligibility rules concerning conditions like renal or hepatic impairment listed in the formal contraindication or specific population sections. The formal exclusion is based solely on a known allergic response to the product's ingredients, making this the primary factor that prohibits use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Genadur (a hydrosoluble nail lacquer) is primarily a topical product; however, it is important to consider its use in the context of any concurrent medications or other nail treatments.

Regulatory information generally advises patients to inform their healthcare provider and pharmacist about all prescription and over-the-counter medications, as well as any vitamins, dietary, or herbal supplements they are currently using. This is a standard precautionary measure for minimizing the potential for any unforeseen interactions.

Procedural and Product-Specific Considerations

Product Category Interaction Note
Specific Medicines/Supplements No specific drug names or substance classes are explicitly listed in the official labeling as having a documented interaction mechanism.
Cosmetic Products The nail lacquer can be applied beneath a cosmetic colored nail polish. This procedural allowance is noted to help protect the nails from the potential drying or damaging effects of solvents found in polish removers.

No formal pharmacokinetic interactions (e.g., enzyme induction or inhibition, transporter effects) are described in the official product information for this topical nail lacquer. The interaction profile is generally defined by a broad advisory to discuss all concomitant product use with a healthcare professional.

Mechanism of Action

Genadur is formulated as a hydrosoluble nail lacquer that functions primarily through a biophysical mechanism on the ungual tissue. Its core active component is hydroxypropyl chitosan (HPCH), a hydrophilic polysaccharide derived from chitin. Upon topical application to the nail plate, the solvent phase evaporates, allowing the HPCH to self-assemble into a semi-occlusive film that adheres strongly to the keratin matrix of the nail.

This film acts as a molecular scaffold and an external physical barrier, modulating the exchange of moisture and preventing external mechanical and chemical stressors from reaching the underlying keratin. The structural integrity of the nail is further modulated by the deposition of sulfur and silica, supplied by complementary components such as methyl sulfonyl methane and Equisetum arvense extract. These minerals are integrated into the keratin structure, a process termed remineralization, which directly increases the rigidity, tensile strength, and flexural strength of the nail plate.

This system-level physiological consequence is a direct biophysical stabilization of the nail's structure, which decreases its mechanical susceptibility to external shear, friction, and environmental desiccation by maintaining hydration and improving the cohesion of the keratinized layers.

Dosage and Administration Information

Official Administration Instructions for Genadur

Genadur is a topical hydrosoluble nail lacquer used for administration directly onto the nail plate. The official instructions for use mandate a specific, daily application regimen to ensure correct use, as outlined in regulatory documents.


Administration Details

Instruction Domain Official Requirement (Route and Dosing)
Route of Administration Topical (onto the nail)
Application Frequency Once daily
Dosing Rule Apply a thin layer on the affected nail(s)
Pre-Application Nails must be clean and dry before application

Procedural Steps

The correct use of Genadur follows a structured, daily routine:

  1. Ensure the affected nail(s) are thoroughly clean and dry prior to application.
  2. Use the supplied brush to apply a thin layer of the product onto the entire affected nail(s).
  3. The application is preferably done before bedtime, as the film is hydrosoluble (water-soluble) and should be applied after washing and drying the nails.
  4. Close the bottle immediately after use.

Special Conditions

If a dose is missed, continue the next day with the regular regimen; there are no complex procedures for missed doses. This product may also be used under a cosmetic colored nail polish, a condition specified in the official labeling. No specific age-group administration rules are explicitly documented for use beyond the standard instructions for adults.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Genadur

Evidence for Nail Fragility and Structural Weakness

Research on the topical lacquer component (Hydroxypropyl Chitosan, MSM) was studied for outcomes related to physical discomfort and patient-reported outcomes describing perceived discomfort linked to brittle nail syndrome. These trials primarily included adults experiencing brittle or splitting nails. Short-term, assessor-blinded studies monitored outcomes such as changes in the nail plate. Research highlights changes measured during the study period, with some findings suggesting measurable differences in nail hardness and monitored changes in the severity of lamellar splitting (nail splitting) when compared to baseline measurements.

However, research is ongoing, and certainty remains low regarding the isolated, long-term outcomes of the topical component. The overall evidence quality varies across studies, and few data are available characterizing the performance of the topical component when used alone without the oral Biotin supplement.

Research on Supporting Symptoms in Nail Psoriasis

This research examines the supportive role of the topical lacquer component in managing the visual signs of mild to moderate nail psoriasis. The trials were randomized, controlled studies involving adult patients. Research examined outcomes linked to inflammatory or irritative states using objective clinical scoring systems, such as the Modified Nail Psoriasis Severity Index (mNAPSI).

Some trials reported differences in the mNAPSI scores when compared against an inert vehicle (placebo). Findings contribute to understanding symptom patterns and the clinical course of nail-related symptoms in this population. Comparative evidence is lacking for how this supportive treatment interacts with other highly potent, systemic psoriasis therapies.

The Study Landscape for Oral Biotin (The Systemic Component)

The evidence base for the oral Biotin component relies significantly on small, retrospective analyses, case series, and older uncontrolled studies. For general brittle nail issues, the systemic component was studied for outcomes related to structural changes, such as objective nail plate thickness. The findings describe patterns observed in the studies, where a percentage of patients reported changes in nail quality and hardness over long observation periods, sometimes exceeding a year. Evidence quality varies across studies, and limited information is available for long-term outcomes and the durability of any observed changes after supplementation is stopped.

Key Studies & References

  1. Effects of a Novel Nail Lacquer Based on Hydroxypropyl-Chitosan (HPCH) in Subjects with Fingernail Onychoschizia
  2. Biotin Fact Sheet for Consumers - NIH Office of Dietary Supplements (Authoritative Source for Biotin Evidence Gaps)

Frequently Asked Questions (FAQ)

Common questions about Genadur (FAQ)

Q: How long does it take to see the full effects of Genadur?

Studies examining the systemic Biotin component have reported observations over long periods, sometimes exceeding a year. These observation periods were used to assess changes in nail quality and structure.


Q: Can Genadur be used by children?

Official administration instructions for Genadur do not contain specific age-group rules beyond the standard guidance provided for adults. This means there are no special or separate instructions documented for use in pediatric populations.


Q: Is Genadur safe for people with kidney issues?

Official documents regarding eligibility and contraindications do not list explicit restrictions related to kidney (renal) or liver (hepatic) impairment. The formal exclusion criteria focus primarily on known hypersensitivity to the product's components.


Q: Can Genadur be taken with Tylenol or Advil?

According to the official product information, no specific drug names or substance classes are listed as having documented interaction mechanisms with Genadur. This includes common over-the-counter pain relievers.


Q: Does Genadur interact with blood pressure medicine?

Official product information does not list specific drug names or substance classes, including common blood pressure medications, as having documented interaction mechanisms with Genadur.


Q: Is Genadur a high-risk medication?

The official safety profile reports systemic adverse effects with low frequency, as the Biotin component is a water-soluble vitamin. However, it does note the rare potential for severe hypersensitivity (anaphylaxis) and contains a critical warning regarding interference with certain lab tests.


Q: Can Genadur be used for long-term conditions?

The product is indicated for the support of chronic conditions such as nail dystrophy and fragility. Studies involving the systemic Biotin component have been conducted with long observation periods to monitor changes in nail structure.


Q: Do older adults need a different dose of Genadur?

The official administration instructions do not document any explicit administration rules or dosing modifications for older adults beyond the standard guidance provided for adults.


Q: What makes Genadur different from similar treatments?

Genadur is officially described as a distinctive dual-component therapeutic system. It is unique in that it combines a systemic oral Biotin supplement with a specialized hydrosoluble nail lacquer that adheres directly to the nail keratin.


Q: Does taking Genadur require any special monitoring?

Official safety notes contain a critical warning that the Biotin component may interfere with certain laboratory immunoassay tests. This could potentially lead to incorrect test results for other medical conditions. The official warning notes the potential need for awareness when undergoing these tests.


Q: What are the most commonly reported side effects of Genadur?

The majority of reported adverse reactions fall into lower frequency categories, such as "Rare" or "Frequency Not Known." These include reports of mild nausea, localized irritation or redness at the application site, and rare hypersensitivity reactions like hives or generalized skin rash.


Q: Is it important to take Genadur at the same time every day?

The official instructions for the nail lacquer component require once-daily application. The application is preferably done before bedtime, as the product is water-soluble (hydrosoluble).


Q: Why is Genadur prescribed for [Condition X]? (Placeholder for a specific condition)

Genadur is indicated to provide structural support for fragile or splitting nails associated with nail dystrophy. The topical component has also been specifically researched for its supportive role in managing the visual signs of certain nail conditions, such as mild to moderate nail psoriasis.


Q: Is it true that Genadur only works for certain types of people?

The formal restrictions on using Genadur are based on specific contraindications. Use is prohibited only for individuals with a known history of hypersensitivity (allergy) to any component of the formulation, or for use in certain areas like open wounds.


Q: How quickly does Genadur start working?

Studies have been conducted to monitor changes in the nail plate over short-term periods. The research examines measurable differences in nail hardness and changes in lamellar splitting when compared against baseline measurements.


Q: Are headaches a common side effect of Genadur?

Headache is not listed among the adverse reactions officially documented in regulatory sources for Genadur. The documented side effects typically involve mild nausea, localized irritation, or rare hypersensitivity reactions.


Q: Is it normal to feel tired when taking Genadur?

Tiredness or fatigue is not listed among the adverse reactions officially documented in regulatory sources for Genadur.


Q: Are there any foods or drinks to avoid while using Genadur?

Official product labeling does not explicitly list specific food or drink substances that are known to have documented interaction mechanisms with Genadur.


Q: Is Genadur safe to take while pregnant or breastfeeding?

Official documents reference the importance of discussing use during pregnancy or planning for pregnancy with a healthcare provider. Consultation with a healthcare provider is also referenced for use while breastfeeding.


Q: Does Genadur show up on a drug test?

Regulatory authorities have noted that the Biotin component of Genadur can interfere with certain types of laboratory immunoassay tests. This interference may result in incorrect test results, which is a critical constraint for monitoring or diagnosing other medical conditions.


Q: Are there any warnings about Genadur and alcohol?

Official product information does not list specific warnings or documented interactions regarding the use of alcohol with Genadur.


Q: Can Genadur affect my mood or mental state?

Effects on mood or mental state are not listed among the adverse reactions officially documented in regulatory sources for Genadur. The documented safety profile focuses on physical reactions, such as mild gastrointestinal issues or localized irritation.


Q: Is there a generic version of Genadur available?

Official drug information sources generally indicate that a lower-cost generic version is not available for the Genadur brand product.


Q: Does Genadur have any effect on liver function?

Official documents regarding eligibility and contraindications do not list explicit restrictions related to conditions such as liver (hepatic) or kidney (renal) impairment. The formal exclusion criteria focus primarily on known hypersensitivity to the product's components.


Q: Do certain medications make Genadur less effective?

Official product information does not list specific drug names or substance classes as having documented mechanisms that reduce the effectiveness of Genadur.

How should Genadur be stored and disposed of?

The official labeling for Genadur defines specific storage and handling requirements to maintain product stability.

Storage Conditions

Component Required Temperature Protection Requirements
Nail Lacquer 15 C to 30 C (59 F to 86 F) Protect from heat; Keep from freezing
Biotin Tablet Room temperature Keep from freezing; away from moisture and light

Both components must be stored out of the reach of children. The nail lacquer bottle must be closed immediately after use, and the tamper-evident seal must be intact before initial opening. The tablet component should not be refrigerated.

Disposal

Regulatory instructions require that outdated or no longer needed medicine should not be kept. Consult a pharmacist or local waste disposal service for specific guidance on the proper method for discarding unused or expired product in accordance with local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Genadur found in:

A-Z Index: